Zhengye Biotechnology Holdings Inc. (ZYBT) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Zhengye Biotechnology Holdings Inc. (ZYBT:NASDAQ), powered by AI.

Current Price
$0.84
Sector
Healthcare
What is the Zhengye Biotechnology Holdings Inc. stock price forecast?

Zhengye Biotechnology Holdings Inc. is currently trading at $0.84. View real-time AI analysis on Alpha Lenz.

What is Zhengye Biotechnology Holdings Inc. insider trading activity?

View the latest insider trading data for Zhengye Biotechnology Holdings Inc. on Alpha Lenz.

What is Zhengye Biotechnology Holdings Inc.'s P/E ratio?

View Zhengye Biotechnology Holdings Inc.'s valuation metrics on Alpha Lenz.

Zhengye Biotechnology Holdings Inc.

NASDAQ · ZYBT
$0.84+0.04(+4.66%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Zhengye Biotechnology Holdings Inc.'s future dividend policy...
Alpha Chat Insight

Zhengye Biotechnology Holdings Inc.'s ROE is -26.1%. Explore profitability and growth together.

Ask for details

Company Overview

Zhengye Biotechnology Holdings Inc. is a company specializing in the development and production of biotechnology solutions, particularly within the field of agribusiness. Its primary function is to provide advanced biotechnology products and services that enhance agricultural productivity and crop protection. This involves the creation of biological fertilizers, pesticides, and growth regulators that are eco-friendly and designed to promote sustainable farming practices. Zhengye Biotechnology Holdings Inc. significantly impacts the agriculture sector by helping farmers increase yields and improve crop quality, thus supporting global initiatives aimed at food security and sustainable agricultural development. The company's contributions extend beyond agriculture as it also engages in research and innovation, positioning itself as a leader in the biotechnology industry. By focusing on environmentally sustainable solutions, Zhengye Biotechnology Holdings Inc. plays a vital role in enabling the agricultural sector to meet the growing demands of food production whilst minimizing environmental impact.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees277

Company Statistics

FY 2025

Profile

N/AMarket Cap
$116.36MRevenue
0.00Shares Out
277Employees

Margins

20.51%Gross
-36.38%EBITDA
-58.66%Operating
-61.77%Pre-Tax
-71.30%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-23.54%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-17.85%ROA
-26.15%ROE
-14.73%ROIC

Financial Health

$50.33MCash & Cash Equivalents
$79.42MNet Debt
42.31%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Zhengye Biotechnology Holdings Inc. (ticker: ZYBT) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 277 employees.

The current price is $0.843 with a P/E ratio of -x and P/B of -x.

ROE is -26.15% and operating margin is -58.66%. Annual revenue is $116M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Zhengye Biotechnology Holdings Inc. (ZYBT) Stock Forecast 2026 $0.84 — Price, Financials & Analyst Targets | Alpha Lenz